Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Watkins, Linda R.
Hutchinson, Mark R.
Ledeboer, Annemarie
Wieseler-Frank, Julie
Milligan, Erin D.
and
Maier, Steven F.
2007.
Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids.
Brain, Behavior, and Immunity,
Vol. 21,
Issue. 2,
p.
131.
Rolan, Paul
Gibbons, Jacqueline A.
He, Lin
Chang, Eppie
Jones, Drew
Gross, Matthew I.
Davidson, Jennifer Bahr
Sanftner, Laura M.
and
Johnson, Kirk W.
2008.
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses.
British Journal of Clinical Pharmacology,
Vol. 66,
Issue. 6,
p.
792.
Hanna-Mitchell, Ann T
and
Birder, Lori A
2008.
New insights into the pharmacology of the bladder.
Current Opinion in Urology,
Vol. 18,
Issue. 4,
p.
347.
Rahn, Elizabeth J.
Zvonok, Alexander M.
Thakur, Ganesh A.
Khanolkar, Atmaram D.
Makriyannis, Alexandros
and
Hohmann, Andrea G.
2008.
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 327,
Issue. 2,
p.
584.
Hook, Michelle A.
Moreno, Georgina
Woller, Sarah
Puga, Denise
Hoy, Kevin
Balden, Robyn
and
Grau, James W.
2009.
Intrathecal Morphine Attenuates Recovery of Function after a Spinal Cord Injury.
Journal of Neurotrauma,
Vol. 26,
Issue. 5,
p.
741.
Bradley, Laurence A.
2009.
Pathophysiology of Fibromyalgia.
The American Journal of Medicine,
Vol. 122,
Issue. 12,
p.
S22.
Sanftner, L. M.
Gibbons, J. A.
Gross, M. I.
Suzuki, B. M.
Gaeta, F. C. A.
and
Johnson, K. W.
2009.
Cross-species comparisons of the pharmacokinetics of ibudilast.
Xenobiotica,
Vol. 39,
Issue. 12,
p.
964.
Sloane, Evan
Ledeboer, A.
Seibert, W.
Coats, B.
van Strien, M.
Maier, S.F.
Johnson, K.W.
Chavez, R.
Watkins, L.R.
Leinwand, L.
Milligan, E.D.
and
Van Dam, A.M.
2009.
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
Brain, Behavior, and Immunity,
Vol. 23,
Issue. 1,
p.
92.
Lee, J.W.
Siegel, S.M.
and
Oaklander, A.L.
2009.
Effects of distal nerve injuries on dorsal-horn neurons and glia: Relationships between lesion size and mechanical hyperalgesia.
Neuroscience,
Vol. 158,
Issue. 2,
p.
904.
Rolan, P
Hutchinson, MR
and
Johnson, KW
2009.
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease.
Expert Opinion on Pharmacotherapy,
Vol. 10,
Issue. 17,
p.
2897.
Crommelin, Daan
Stolk, Pieter
Besançon, Luc
Shah, Vinod
Midha, Kamal
and
Leufkens, Hubert
2010.
Pharmaceutical sciences in 2020.
Nature Reviews Drug Discovery,
Vol. 9,
Issue. 2,
p.
99.
Cho, Yoonsang
Crichlow, Gregg V.
Vermeire, Jon J.
Leng, Lin
Du, Xin
Hodsdon, Michael E.
Bucala, Richard
Cappello, Michael
Gross, Matt
Gaeta, Federico
Johnson, Kirk
and
Lolis, Elias J.
2010.
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 25,
p.
11313.
Hennessy, Elizabeth J.
Parker, Andrew E.
and
O'Neill, Luke A. J.
2010.
Targeting Toll-like receptors: emerging therapeutics?.
Nature Reviews Drug Discovery,
Vol. 9,
Issue. 4,
p.
293.
Burgess, Gillian
and
Williams, Dic
2010.
The discovery and development of analgesics: new mechanisms, new modalities.
Journal of Clinical Investigation,
Vol. 120,
Issue. 11,
p.
3753.
Noto, Christopher
and
Pappagallo, Marco
2010.
Analgesia.
Vol. 617,
Issue. ,
p.
539.
EASTMAN, PEGGY
2010.
NIH Pain Consortium Showcases Emerging Approaches to Controlling Pain.
Neurology Today,
Vol. 10,
Issue. 13,
p.
32.
Beardsley, Patrick M.
Shelton, Keith L.
Hendrick, Elizabeth
and
Johnson, Kirk W.
2010.
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.
European Journal of Pharmacology,
Vol. 637,
Issue. 1-3,
p.
102.
Berger, Julie V.
Knaepen, Liesbeth
Janssen, Sofie P.M.
Jaken, Robby J.P.
Marcus, Marco A.E.
Joosten, Elbert A.J.
and
Deumens, Ronald
2011.
Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches.
Brain Research Reviews,
Vol. 67,
Issue. 1-2,
p.
282.
Keogh, Brian
and
Parker, Andrew E.
2011.
Toll-like receptors as targets for immune disorders.
Trends in Pharmacological Sciences,
Vol. 32,
Issue. 7,
p.
435.
Dunne, Aisling
Marshall, Neil A
and
Mills, Kingston HG
2011.
TLR based therapeutics.
Current Opinion in Pharmacology,
Vol. 11,
Issue. 4,
p.
404.